Zaffar H. An introduction to diabetic neuropathy: a review. World J Pharm Sciences. 2016;4(5):242-252
Schaper NC, van Netten JJ, Apelqvist J, IWGDF Editorial Board, et al. Practical guidelines on the prevention and management of diabetes-related foot disease (IWGDF 2023 update). Diabetes Metab Res Rev. 2024;40(3): e3657. doi:10.1002/dmrr.3657
Hingorani A, LaMuraglia GM, Henke P, et al. The management of the diabetic foot: a clinical practice guideline by the Society for Vascular Surgery in collaboration with the American Podiatric Medical Association and the Society for Vascular Medicine. J Vasc Surg. 2016;63(2 Suppl):3S-21S. doi:10.1016/j.jvs.2015.10.003
Conte MS, Bradbury AW, Kolh P, CVG Writing Group, et al. Global vascular guidelines on the management of chronic limb-threatening ischemia. J Vasc Surg. 2019;69(6S):3S125S.e40. doi:10.1016/j.jvs.2019.02.016
Uccioli L, Meloni M, Izzo V, Giurato L, Merolla S, Gandini R. Critical limb ischemia: current challenges and futures perspectives. Vasc Health Risk Manag. 2018;14:63-74. doi:10.2147/VHRM.S125065
Rosenberger DC, Blechschmidt V, Timmerman H, Wolff A, Treede RD. Challenges of neuropathic pain: focus on diabetic neuropathy. J Neural Transm (Vienna). 2020;127(4):589-624. doi:10.1007/s00702-020-02145-7
Alexandrescu VA, Van Overmeire L, Makrygiannis G, et al. Clinical implications of diabetic peripheral neuropathy in primary infrapopliteal angioplasty approach for neuro-ischemic foot wounds. J Endovasc Ther. 2023;30(6):920-930. doi:10.1177/15266028221106312
Finnerup NB, Haroutounian S, Kamerman P, et al. Neuropathic pain: an updated grading system for research and clinical practice. Pain. 2016;157(8):1599-1606. doi: 10.1097/j.pain.0000000000000492
Tesfaye S, Boulton AJM, Dyck PJ, Toronto Diabetic Neuropathy Expert Group, et al. Diabetes neuropathies: update on definitions, diagnostic criteria, estimation of severity, and treatments. Diabetes Care. 2010;33(10):2285-2293. doi:10.2337/dc10-1303
Young MJ, Boulton AJ, MacLeod AF, Williams DR, Sonksen PH. A multicentre study of the prevalence of the diabetic peripheral neuropathy in the United Kingdom hospital clinic population. Diabetologia. 1993;36(2):150-154. doi:10.1007/BF00400697
Scholz J, Finnerup NB, Attal N, Classification Committee of the Neuropathic Pain Special Interest Group (NeuPSIG), et al. The IASP classification of chronic pain for ICD-11: chronic neuropathic pain. Pain. 2019;160(1):53-59. oi:10.1097/j.pain.0000000000001365
Shang Y, Cheng Z, Dongye Z, Shuangmei L. Different types of cell death in diabetic neuropathy: a focus on mechanisms and therapeutic strategies. Int J Mol Sci. 2024;25(15):8126. doi:10.3390/ijms25158126
Jensen TS, Karlsson P, Gylfadottir SS, et al. Painful and non-painful diabetic neuropathy, diagnostic challenges and implications for future management. Brain. 2021;144(6):1632-1645. doi:10.1093/brain/awab079
Dyck PJ, Albers JW, Andersen H, Toronto Expert Panel on Diabetic Neuropathy, et al. Diabetic polyneuropathies: update on research definition, diagnostic criteria and estimation of severity. Diabetes Metab Res Rev. 2011;27(7):620-628. doi:10.1002/dmrr.1226
England JD, Gronseth, GS, Franklin G, American Academy of Neurology, et al. Practice parameter: evaluation of distal symmetric polyneuropathy: role of autonomic testing, nerve biopsy, and skin biopsy (an evidence-based review). Report of the American Academy of Neurology, American Association of Neuromuscular and Electrodiagnostic Medicine, and American Academy of Physical Medicine and Rehabilitation. Neurology. 2009;72(2):177-184. doi:0.1212/01.wnl.0000336345.70511.0f
Dyck PJ, Overland CJ, Low PA, Cl vs. NPhys Trial Investigators, et al. Signs and symptoms versus nerve conduction studies to diagnose diabetic sensorimotor polyneuropathy: Cl vs. NPhys trial. Muscle Nerve. 2010;42(2):157-164. doi:10.1002/mus.21661
Bäckryd E, Themistocleous A, Larsson A, et al. Eleven neurology‐related proteins measured in serum are positively correlated to the severity of diabetic neuropathy. Sci Rep. 2024;14(1):17068. doi:10.1038/s41598-024-66471-6
Patrone L, Pasqui E, Conte MS, et al. The “woundosome” concept and its impact on procedural outcomes in patients with chronic limb-threatening ischemia. J Endovasc Ther. 2024;15266028241231745. doi:10.1177/15266028241231745
Jiang X, Yuan Y, Ma Y, et al. Pain management in people with diabetes-related chronic limb-threatening ischemia. J Diabetes Res. 2021;6699292. doi:10.1155/2021/6699292
Jörneskog G. Why critical limb ischemia criteria are not applicable to diabetic foot and what the consequences are. J Scan Surg. 2012; 101(2):114-118. doi:10.1177/145749691210100207
Mustapha JA, Diaz-Sandoval LJ, Saab F. Infrapopliteal calcification patterns in critical limb ischemia: diagnostic, pathologic and therapeutic implications in the search for the endovascular holy grail. J Cardiovasc Surg (Torino). 2017;58(3):383401. doi:10.23736/S0021-9509.17.09878-0
Tehan PE, Mills J, Leask S, et al. Toe-brachial index and toe systolic blood pressure for the diagnosis of peripheral arterial disease. Cochrane Database Syst Rev. 2024;10(10):CD013783. doi:10.1002/14651858.CD013783
